Jeroen Nieuwland
Senior Lecturer Biology, Faculty of Computing, Engineering and Science - University of South Wales

Download Presentation

Sue Bale
Director for Research and Development, Aneurin Bevan University Health Board

Sue was appointed R&D Director in June 2014. Sue joined the University Health Board as Associate Nurse Director (R&D) in 2004 and she has worked in clinical practice and research both in the NHS and in Universities since 1979. Her clinical, educational and research interest is wound healing, where she has published widely over the past 34 years. Sue is currently the Editor of the European Wound Management Association Journal, Executive Board Member, and lead for Communications. For this work she was awarded a Fellowship to the Royal College of Nursing in 2004 and an OBE in 2013.

Jenna Bowen
Chief Operating Officer, Cotton Mouton Diagnostics

Darren Clark
Chief Executive, Medilink East Midlands

Darren has been with Medilink East Midlands, since 2004. In his role as Chief Executive, he has successfully overseen the development of the company into one of the key players in the Medilink UK network. In addition to the national work, he has successfully overseen the delivery of a number of significant public sector contracts. In 2017 Darren launched Medilink Midlands, a strategic alliance between Medilink East and West Midlands, Darren is a Director of Medilink Midlands.  Prior to joining Medilink, Darren worked for Pharmaceutical Profiles (now Quotient Sciences), one of the East Midland’s many successful Life Science companies. He is a Non-Executive Director of the East Midlands Chamber, Chairs the Charnwood Campus Enterprise Zone Steering Committee and sits on the Board of Trustees for The Ear Foundation. A microbiologist by training, he has a degree from the University of Surrey and a doctorate from the University of Warwick.

 

Michael Graz
Founder and CEO, Biophys

Michael has 25 years of commercial, research and teaching experience in the life sciences, biotechnology and food processing sectors where he has held senior management, advisory and technical consultancy roles. He has managed turnaround situations in corporate environments, established startups and developed services in corporate organisations and with clients who have included governmental and intergovernmental bodies. This has taken him to live on 4 continents and to work across 5. 

With 2 PhDs, numerous publications and joint inventorship on 7 patents in the field of microbial control and diagnostics, Michael has significant insight into antimicrobial resistance in infectious diseases. For the past 10 years he has been active in the diagnostics and biotech sectors in South Wales and in his last role achieved Orphan Designation from the FDA for an anti-virulence factor against Pseudomonas aeruginosa in CF patients. He is currently working on building a Life Sciences Incubator at Mamhilad Park about 30 minutes from Cardiff and developing a Microbiome based treatment for an as yet unnamed chronic condition. 

Robyn Davies
Head of Health Innovation, Cardiff and Vale UHB

Robyn works part of his time as Head of Health Innovation at Cardiff and Vale UHB, part of his time in the South East Wales Academic Health Science Partnership.  He is also Chairman of Cultuvate Ltd on behalf of the Wesley Clover Group. 

Previously he co-founded a successful international consultancy that focused on strategic people solutions to the Tech Sector.  His early career included HR director roles in the NHS and international tech firms.   Way back in the last century he was a general manager for surgery and anaesthetic services in the Welsh NHS.

He has an Occupational Psychology degree and an Executive Health MBA from Cardiff University.  He is a Member of the Institute of Healthcare Management, a Fellow of the Chartered Institute of Personnel and Development and a Fellow of the Royal Society for Public Health.

Andrew Mearns Spragg
Founder & Chief Scientific Officer, Jellagen

Dr Andrew Mearns Spragg  is a scientific entrepreneur and marine biotechnology pioneer with a successful track record of growing venture backed technology businesses.

For the past 18 years, his career has focused on the creation of companies involved with the commercial exploitation of marine biotechnologies. Andrew has successfully raised to date over £16M in equity finance from VCs and Angels and has secured competitive grant funding from EU and UK sources worth >£3M. He was the recipient of the 2007 Gannochy Award and Medal from the Royal Society of Edinburgh, Scotland’s highest award for Innovation and his entrepreneurial achievements were recognised through winning the Ernst & Young Entrepreneur of the year 2008 in Health Care for Scotland. Andrew holds Honorary Professorships from the University of Stirling (2012-2016) and University of the Highlands and Islands. He is a Fellow of the Royal Society of Chemistry and the Royal Society of Biology.

Andrew founded Jellagen in 2013, and established the first manufacturing plant of Jellyfish Collagen as well as building in-house collagen standards and first data sets. He is a member of the Board and Executive Committee, responsible for Scientific and Technology strategy, Product Development and Business Development activities.

Andy Burroughs
Health and Wellbeing Sector Lead - Scale Up Programme, SetSquared

Download Presentation

Clare Skidmore
Futures Connect Project Officer, Cardiff University - Future Connects

Clare has worked in education for over 10 years and joined the Futures Connect Work Experience Team in October 2017. She has a lead in organising extra-curricular work experience for students studying Biomedical and Life Science degrees, as well as for third and public sector organisations. Clare has expertise in equality and diversity from previous roles, and as a result was given the responsibility of supporting our International and EU students with placements – creating and implementing two new schemes; Languages for Business and Languages for Schools. She also has a lead in working with Cardiff University’s Doctoral Academy and have worked closely with them to set up a number of Insights and Internships for Post Graduate Research students.

Christine Henderson
GO Wales Project Officer, Cardiff University - GO Wales

Chartered Fellow of the Ch.CIPD, Associate Member of the Association for Coaching, I joined the GO Wales project at the beginning of October 2018, having worked in senior HR and L&D roles in a variety of sectors.  My background and experience means I can deliver tailored careers guidance and support in finding work experience and actively enable students to fulfil their potential whatever their circumstances or background.  As a coach, I am continuously curious about process improvement – the thoughts, language and behaviours that bring about positive change.  

Sabarna Mukhopadyay
CEO, SymlConnect

Sabarna Mukhopadhyay is the CEO of SymlConnect Ltd. With over 25 years’ experience of managing international multidisciplinary collaboration activities, a strong background in R&D (academia and industry), interpersonal and business development, Sabarna manages and delivers the innovative Syml solutions.

SymlConnect, a user-led informatics company working cohesively with specialists to digitise existing paper processes, designing intelligent end-to-end integrated software solutions to enhance time and cost efficiency. Simple and secure solutions empower clinicians and patients with seamless data transfer and facilitates remote communication where required.

Download Presentation

Ruth Bardell
Project Officer for the Enterprise & Innovation Team, Swansea University - Medical School

Ruth Bardell is a Project Manager on the Enterprise & Innovation team, with ten years experience in delivering novel approaches to health and wellbeing. Her particular interest is mental health in young people.

The Institute of Life Science is the Innovation Hub of Swansea University Medical School. We collaborate with the NHS, business and the third sector in a spirit of open innovation and have established ourselves as a world-class place to learn, research, innovate, collaborate and lead.

Download Presentation

Mark Street Docherty
CEO, Elucigene Diagnostics

Mark has over 12 years’ experience working in healthcare product development and commercialisation, with expertise in the field of In Vitro Diagnostic medical devices. Having been involved in over 50 IVD product launches, Mark has experienced first-hand the successes and pitfalls of product launches in the UK and overseas. Mark now leads an award winning and innovative fast growth genetics In Vitro Diagnostics SME based at CityLabs 1.0 , Manchester, providing a suite of products across 50 international markets. Under his leadership Elucigene Diagnostics has become the international market leading technology provision for the diagnosis of Cystic Fibrosis. The business has an aggressive pipeline of new products aimed at improving global patient and economic outcomes.

Download Presentation

Shiraaz Essop
Procurement Delivery Manager Projects and Transformation, NHS Supply Chain

Shiraaz is an experienced Procurement and Transformation professional who has worked in several functions through a career spanning over 25 years in and around the Health Sector

He has worked at local, regional and national levels within community and acute sectors, as well as within national Procurement and Supply Chain Teams

Whilst working at regional level in the past he has developed analytical processes and led on reviews of expenditure across Trusts to identify aggregation and savings opportunities.  These processes have then been rolled out to other regions to utilise.

Shiraaz considers himself fortunate to have led an interesting and varied professional life,  having not only had the opportunity to work in several category areas, but also to have worked on several large Projects and Transformations within different functions. Most recently supporting the transition of 3 of the new Procurement Category Towers to the New Operating Model of the DH’s Procurement Transformation Programme.

Whilst working within NHS Logistics’ Customer Relationship Management team, Shiraaz was part of the team that rolled out the first online ordering platform for NHS Trusts to order goods electronically via NHS Logistics.

He worked with the World Health Organisation and the NHS in co-ordinating the ordering and delivery of new products and supporting information for the “Clean Your Hands” campaign which helped to reduce MRSA rates across the NHS.

In 2006 Shiraaz was involved in the transition from NHS Supplies to an outsourced procurement model at national level with the creation of NHS Supply Chain.

He is passionate about supply chain efficiencies within the NHS, hence his career has taken him into different functions in order to develop or improve processes with a view to improving the overall supply chain for the NHS.

Shiraaz was honoured in 2016 to chair the Red Chair network within DHL, looking to support the diversity agenda within the UK, which also gave him the opportunity to help mentor disadvantaged teenagers, from which he also learnt a great deal himself. 

Max Gould
Corporate Finance, Cenkos

Max has over 5 years experience advising both public and private companies in debt & equity financing, M&A and restructuring matters. Max works in the corporate finance department within the Growth Companies Team at City-based institutional stockbroker, Cenkos Securities, which specialises in raising equity capital on the AIM market. Max is originally from Perth, Western Australia.

Conor Feehily
SFI Experienced Post-doctoral Researcher, Teagasc

Conor is a Senior Post-doctoral Research Fellow on the Science Foundation Ireland funded research spoke Microbe Mom. This multicentre project aims to understand how microbes are transferred from mothers to baby, including the role of the diet in influencing this transfer.

His research interests lie in microbes that have both a beneficial and detrimental impact on our health, and his research specifically deals with the vaginal microbiota and its role in vaginal health and pregnancy.

After graduating with a PhD in Microbiology from NUI Galway, he joined APC Microbiome Ireland in 2014 to research and develop probiotics, before joining Teagasc in 2017 on an Irish Research Council/ Industry partner funded Post-doctoral Fellowship.

Download Presentation

Greg Richard
Founder, 3DAnatomica

Greg has been a pioneer in interactive healthcare media for 20 years. His input has been recognised internationally with innovation awards and 2 successful international patents.

His knowledge of doctor/patient interaction provided the insight that underpinned the creation of 3DAnatomica.

Previously, Greg founded 3DClinic which successfully demonstrated and produced health management solutions in Australia, USA, Europe and Japan. He was also behind the development of the PushPull Medical library of wireframe models, part of which has been utilised in the new 360+AR digital offering.

With more than 35 years’ experience as a multimedia producer who has specialised in the health industry for more than two decades, Greg has produced widely varied communication programs working with leading pharmaceutical, patient, publishing and media groups.

John Jeans
Chairman, Digital Health & Social Care Institute

John is a Non-Executive Director who chairs the Digital Health and Care Institute and serves on the Boards of EM Imaging, Renishaw plc, ProMetic Life Science Inc. and ProMetic Pharma SMT Ltd. His previous positions include Chairmanships of Imanova Ltd and the UK BioCentre as well as Directorships of Alliance Medical and Myconostica. 

He was previously the Chairman of Cardiff University and a Director of the University Employers Association. From 2009 John was Deputy Chief Executive of the Medical Research Council, a member of its Audit and Risk Committee and Chaired the Trustee Board of MRC Technology (LifeArc) until 2014.

An advisor to public and third sector organizations, he was appointed by the Prime Minister from 2014 to 2018 as the Life Science Champion for medical technology. John leads Innovate UK’s Health KTN Board, and has contributed to advisory panels for the MRC, EPSRC, NIHR, NCUB, NPL and the Wellcome Trust. He has served on several Government bodies including a Ministerial Committee on Medical Technologies, was an inaugural member of the Science Advisory Council for Wales and a founder Trustee of the Francis Crick Institute. He is Chair of the Strategic Advisory Panel for the Singapore Government’s Diagnostics Hub, a member of its Advanced Manufacturing and Engineering Advisory Panel and its Health and Biomedical Sciences Advisory Council.

In an industrial career spanning 35 years he held senior international leadership positions in global companies including Smith & Nephew, Bristol Myers Squibb, Johnson & Johnson and Amersham plc. John headed the commercial function of GE’s Life Science business and was the Chairman of its UK Healthcare Company. His domain experience ranges from medical devices and therapeutic pharmaceuticals to in-vivo and in-vitro diagnostics; encompassing research, product development, manufacturing and commercialization. 

John is engaged with international, national and local charities including the Africa Research Excellence Fund and is Co-Chair of the Clare Foundation.

He was awarded the CBE for services to Life Sciences, Healthcare and Science in 2012.

Christian Kumar
Managing Director, Capital Kinetics

Christian has 25 years of experience in Investment Banking Corporate & Structured Finance, combined with grounding in business strategy, strategic selling and analysis. With an education background in Maths and Finance, he has a logical approach to business whilst adding a creative flare.
He’s worked with a diverse range of funding partners ranging from the likes of Merrill Lynch, HSBC and Goldman Sachs through to Boutique Banks and high net worth private clients and their family offices. His passion as a self-proclaimed “Deal Junkie” is funding and growing innovative and disruptive companies.  With 8 Core companies we serve the pre starts to listed companies.

Download Presentation

Simon Richards
Director, MEDDEV QA

Simon has over 15 years’ experience in the medical device industry. He is a Quality Assurance and Regulatory Affairs specialist in the Medical Device industry with a strong background in Sterilization and Microbiology.  Simon also has an excellent understanding of ISO 13485 Quality Management Systems and is a qualified FDA lead auditor with experience of leading both internal and external audits.  He’s spent over ten years working at a leading UK based notified body as a Certification Manager.

Download Presentation

Alistair Martin
Chief Commercial Officer, Transforming Systems

Alistair has a track record delivering transformational change, operational management and commissioning in the NHS. As a lean six sigma black belt, Alistair is skilled at deploying large scale transformations in extremely challenging environments, which have led to quality enhancements and cost savings.

Alistair has operational experience managing A&E, acute medical and oncology services at scale. Alistair’s has delivered across a range of complex settings, including provider and whole system, across a complex multiple CCG cluster health economy.

Now as an executive Director in a software company, spun out of the University of Greenwich Alistair has successfully led the go to market strategy for SHREWD. This has seen Transforming Systems establish SHREWD as the first real time whole system view of urgent care in the UK. Our sales have grown by 300% in the last 2 years, and now covering 18% of the NHS and on trajectory to double in size within the next 12 months. As part of the Digital Health.London Accelerator programme and as a National Innovation Accelerator fellow, Alistair is leading the business development strategy for embedding a successful predictive programme across acute and emergency care operations.

Download Presentation

Christie Harper
Consultant, Gatehouse ICS

After 15 years in health economic consultancy and, before that a career in cardiac nursing in the UK/USA, Christie Harper established Gatehouse ICS (Independent Commercialisation Support) in 2016. Gatehouse uses Christie’s experience and 8000 + network of pharma, medtech, NHS and academic contacts for two main services: 1) Market Insights interview research for those wishing to sell to or partner with the NHS or industry and 2) Freelance business development and lead generation for health research and related products/services. Her market insights are often used by innovators to gain an early understanding of NHS acceptability of their inventions and also to understand how it might be purchased by the NHS (process, challenges, routes and opportunities). This research is provided to three University IP departments for their associated health innovators and Christie is a member of the consultant network for the Health Tech Hub at University West England, for similar support. She is also trained by the BHBIA in ethics and legal methods surrounding this research. Alongside her health economic career Christie has taught and developed curriculum for University courses in health economics and communications and has delivered seminars such as “health economics for the non health economist” and “consultancy based selling” to a variety of audiences. Gatehouse ICS currently hires one research executive and one NVQ apprentice, with another apprentice appointment planned in 2019. Christie has also founded RAISE Community Interest Company (CIC), which aims to raise awareness, aspirations and opportunities for school leavers in the South Wales Valleys in relation to health innovation careers and study paths.

Download Presentation

Liz Hayward
HR Manager, Creo Medical

Dr Dean Burnett
Neuroscientist, Comedian and Guardian science blogger,

Dean Burnett is a doctor of neuroscience, international bestselling, in-demand speaker and science communicator and sometimes comedian. He is currently travelling the UK telling people all about the intricate properties of our brains that determine what makes us happy and why, as covered in his latest book ‘The Happy Brain’. He is based in Cardiff and is an honorary research associate for the psychology school at the university.

Download Presentation

David Sheppard
Deputy Head, Life Sciences, Department for International Trade

David Sheppard joined the DIT Life Sciences Organisation in June 2015 and is responsible for leading a team of civil servants and sector specialists to help UK companies to export life sciences products and services and attract Foreign Direct Investment.

After graduating from Swansea University in History and working for the Gwent-Glamorgan Archaeological Trust, David joined the Ministry of Defence in 1989. Whilst in Defence he worked in equipment procurement, international defence co-operation, the 2001 Armed Forces Parliamentary Act and Human Resources.

Outside the Ministry of Defence, David has held the posts of Assistant Director for Africa and the Middle East in the UKTI Defence and Security Organisation and Head of Trade and Investment in the British Embassy in Muscat, Oman, where his tour culminated with the signature of a contract worth £2.5 billion to supply 12 Typhoon aircraft to the Royal Air Force of Oman witnessed by the Prime Minister.

Peter Finegold
Head of Education, Institution of Mechanical Engineers (IMechE)

Peter joined the Institution of Mechanical Engineers in 2013 as Head of Education, since when he has led a programme of research to influence policy and practice linked to engineering skills. He started out his career as a biology, science and psychology teacher working in comprehensive schools in East Sussex and inner London for ten years, before joining the Wellcome Trust, where he oversaw the charity’s schools work, developed its education policy activity and conceived and led the 5-year development of the Science Learning Centres initiative (now STEM Learning) with Government. He worked extensively on modernising genetics education and STEM education policy, including co-authorship with Sir John Holman of the STEM Careers Review for the Gatsby Charitable Foundation.

Download Presentation

Gwyn Tudor
CEO, MediWales

As CEO of Mediwales for nearly 16 years, Gwyn has overseen a transformation of the forum to its current size, influence and corporate structure. Gwyn works with the directors and members of MediWales to develop the forum’s future strategic direction. His in-depth knowledge of the life science sector allows him to represent MediWales’ members’ interests on a number of Welsh and UK government panels and boards.

Gwyn’s career has developed over twenty years from being a front line product designer working in a number of sectors, including the development of medical devices, to his current managerial role.

Michael Clark
Commercial Director, Welsh Wound Innovation Centre

Michael Clark is Commercial Director, Welsh Wound Innovation Centre and Director of the Welsh Wound Network. A zoologist by training, Professor Clark has worked in tissue viability and wound healing since 1980.  He is Professor of Wound Study, Birmingham City University supporting their Wound Healing Practice Development Unit one day a week.     Between 2003 and 2009 he was a member of the Wound Healing Research Unit, Cardiff University and had responsibility for physical measurement research within the WHRU.  From 2009-2013 Professor Clark managed the Welsh Wound Network while also acting as an independent consultant.  Professor Clark was Chief Executive of the Lindsay Leg Club Foundation and has been a recent President of the European Pressure Ulcer Advisory Panel.  He was Editor in Chief of the Journal of Tissue Viability from 2000 to 2010 and now serves as Emeritus Editor of that publication.

Download Presentation

Chris Marshall
Director, Cardiff University – Wales Research and Diagnostic Positron Emission Tomography Imaging Centre (PETIC)

Prof Marshall is a state registered Clinical Scientist specialising in Nuclear Medicine, Radiopharmaceutical Production, Quality Management and Positron Emission Tomography. Prof Marshall joined PETIC in 2010 to take up the post of Operations Director after spending 6 years as Head of Radioisotopes in Northern Ireland and previously working at Lincoln and Aberdeen. In 2013, Prof Marshall was promoted to Director of PETIC in 2013 and has since significantly increased patient throughput and research activity within the facility.

In 2000, Prof Marshall commenced a part time PhD with the University of Aberdeen and successfully submitted his thesis on the role of Molecular Imaging in Monitoring and Predicting the Response of Breast Cancer to Neoadjuvant Chemotherapy in 2004.

Prof Marshall’s major achievements include designing, commissioning and project managing the new nuclear medicine facilities at the Royal Victoria Hospital and Northern Ireland Cancer Centre and the cyclotron facilities in both Belfast and Cardiff and well as leading on the introduction of an all Wales PET service and the production of several novel radiotracers and radiometals.

Download Presentation

David Thompson
Managing Director and Principal Consultant, Clarity Compliance Solutions

David Thompson, Managing Director & Principal Consultant of Clarity Compliance Solutions is a Data Integrity, Computer Systems Validation and Compliance expert.

He has worked in the IT/Computer Systems arena for almost 30 years, the last 18 years he has provided Strategic Governance and Consultancy, Auditing and Training services to the pharmaceutical, biotech, R&D, medical devices, bloods and healthcare industry and to their suppliers of equipment and computerised systems, across the UK, Europe, Far East, Asia and the U.S.A.

Working across a wide variety and scale of organisations (top 5, mid-sized, generics, medical devices, CMO’s, CRO’s), David has an established pedigree of bringing his experience in technical, procedural methodologies and project implementations to site, country and global projects and programs for the benefit of his clients.

Recent activities include Global Head of Quality for GxP SaaS global program and also delivering Data Integrity expertise, Auditing, Consulting, Training and Program Implementations where by Data Integrity is woven in to the organisational fabric of clients.

David is a Chartered Engineer with both the MIET and the MInstMC and a member of the GAMP MES SIG and GAMP DI SIG.

Download Presentation

Mark Birse
Group Manager Medical Device Safety and Surveillance & Software and Apps, Medicines and Healthcare products Regulatory Agency (MHRA)

Mark is the Group Manager of MHRA Devices Safety and Surveillance Group & Devices Software and Apps Group. He joined the MHRA in 2002 as a GMP Inspector having previously worked in the pharmaceutical industry for over 10 years and eligible to be a Qualified Person.Formerly Mark was the Deputy Director of the Inspection, Enforcement and Standards Division and Head of the MHRA Inspectorate & Process Licencing (covering GCP, GDP, GLP, GMP & GPvP)

Ifan Evans
Director Technology & Transformation, Health & Social Services Group, Welsh Government

Ifan is the Welsh Government lead for technology and innovation in health and care, working closely with NHS Wales, universities and businesses to support open innovation partnerships, and the use of new and emerging technologies.  He also leads the delivery of A Healthier Wales, the new national plan for health and social care in Wales.  Ifan has degrees from Oxford, Cardiff and Aberystwyth Universities. He has a private sector background with experience in property, retail, leisure, and tourism, and has also served on the boards of a number of social enterprises.

Download Presentation

Lars Sundstrom
Innovation and Growth Director, West of England Academic Health Science Network

Lars Sundstrom is Director of Innovation and Growth at the West of England Academic Health Science Network and is responsible for developing new partnerships between companies and healthcare providers. Lars has over 30 years experience working between industry, academia and healthcare organisations and has held several executive and board level positions in companies and local health sector groups. He has also been an adviser to several UK and Local Government task forces as well as an adviser to the European Commission. 

Download Presentation

Dr Richard Thompson
Senior Investment Executive, Development Bank of Wales

Richard works for the Development Bank’s specialist Technology Venture Investments Team. He specialises in equity co-investments for a wide range of technology companies based in Wales and those keen to move here. As well as making new investments he current represents the Bank interests on the boards of many portfolio companies.

His life science investments include: Creo Medical (now listed and raised over £80m), Q-Chip (acquired by MidaTech Pharma with a concurrent listing), Clinithink, PulmonIR, Momentum and Calon Cardio.

Earlier in his career he managed the pan-Wales University Spinout Programme which helped Welsh Universities to start up and fund innovative businesses and was a senior consultant with the UK’s leading construction sector consultants – BRE in Garston. He also held a number of roles in research and development, commercialisation and manufacturing in Australia, the Netherlands and Wales.

Richard has a PhD in materials science and a BEng (Hons) in materials science and engineering both from the University of Bath.

Download Presentation

Cynthia Bullock
Senior Innovation Lead for Enabling Programmes, Innovate UK

Cynthia leads on the Biomedical Catalyst, SBRI and Investor Relations programmes within the Ageing Society Health and Nutrition sector at Innovate UK, the UK’s innovation agency which is part of UKRI.  These programme together represent over £400m of investment.  Cynthia works with the Department of Health and Social Care, its agencies (such as the NHS) and other relevant public bodies to support the development and procurement of R&D solutions which address defined needs.

Cynthia has over 15 year’s background in healthcare initially as a post-doctoral scientist in biochemistry and molecular biology then moving on to lead and project manage translational research across several clinical departments at Guys and St Thomas’ and Oxford University Hospitals.  In her most recent role Cynthia established a new team at an acute NHS Trust to oversee research and innovation support functions and developed the first Innovation Challenge Fund to specifically support NHS staff with bright ideas.  She has extensive experience of intellectual property management, contract negotiation, grant management and business development.  Cynthia has an executive MBA from Imperial College London.

Download Presentation

Hamish Laing
Professor of Enhanced Innovation, Engagement and Outcomes, Swansea University School of Management

After a career as a reconstructive plastic surgeon and sarcoma specialist, spanning England and Wales, and holding many NHS leadership positions, Hamish was Executive Medical Director and Chief Information Officer at ABM University Health Board (ABMU) from 2014-8. He led a cross-sectoral review of clinical and digital strategies, co-authored its quality strategy, and secured substantial investment for digital transformation.  He established a Value-Based Healthcare programme and was instrumental in ARCH and the Swansea Bay City Region Deal.

In his new role in Swansea University, Hamish will promote the understanding and application of Value-Based Healthcare, develop and test models of outcomes-based pricing for medicines and evaluate technologies that support medicines adherence; working closely with Pfizer Inc., NHS Wales and other partners. Hamish is passionate about digital inclusion for patients and staff in the NHS and remains SRO for the national migration of NHS Wales Websites to an improved design and content management system and also the project to deploy and evaluate a patient controlled health record, Patients Know Best™ in ABMU.

Download Presentation

Dr Peter Groves
Chair, Medical Technologies Advisory Committee NICE & Chair, Devices Expert Advisory Committee MHRA, NICE

Dr Groves is a Consultant Interventional Cardiologist at the University Hospital of Wales, Cardiff and leads the structural heart disease interventional programme in south-east Wales. In addition to his clinical and academic involvement in the use of medical devices, Dr Groves has an interest in the regulation, health technology assessment and implementation of innovative technologies into clinical practice. Dr Groves holds national leadership positions in three government sponsored organizations in the UK. Dr Groves is Chair of the NICE Medical Technologies Advisory Committee which promotes the adoption of novel and innovative medical device technologies in the NHS. Dr Groves is Chair of the Devices Expert Advisory Committee that provides clinical, academic and operational advice to the MHRA in the regulation of medical devices in the setting of the UK healthcare system. Dr Groves is Chair of Health Technology Wales, an organization that is sponsored by Welsh Government to identify, appraise and promote the adoption of medical devices in NHS Wales. Dr Groves was previously Director of Cardiothoracic Services at the University Hospital of Wales, President of the Welsh Cardiovascular Society and Council member of the British Cardiovascular Society. Dr Groves has a continued interest in teaching and research and holds the position of Lecturer at Cardiff University.

Download Presentation

Mark Steedman
Research Manager, Deloitte Centre for Health Solutions

Mark is the Research Manager for the Deloitte UK Centre for Health Solutions, which seeks to be a trusted source of relevant, timely and reliable insights that encourage collaboration across the health value chain. The Centre’s goal is to identify emerging trends, challenges, opportunities and examples of good practice, based on primary and secondary research and rigorous analysis. Until November 2016, Mark was the Institute Manager and a Policy Fellow at the Institute of Global Health Innovation at Imperial College London, where he supported research on palliative and end-of-life care, maternal and child health, design, philanthropy and electronic health records. Mark has a PhD from the UC Berkeley – UCSF Graduate Programme in Bioengineering, where he worked with Professor Tejal Desai on retinal tissue engineering and drug delivery. He also completed a Whitaker International Postdoctoral Fellowship with Professor Molly Stevens in the Departments of Materials and Bioengineering at Imperial College London.

Download Presentation

Sheryl Warttig
Senior Technical Adviser, National Institute for Health and Care Excellence

Sheryl Warttig is a senior technical adviser in NICE’s Centre for Health Technology Evaluation. Sheryl is leading the delivery of HealthTech Connect- a national, systematic approach for identifying and supporting health technologies including devices, diagnostics, apps, and wearables. HealthTech Connect will be used by NICE, NHS England, and other UK healthcare decision makers as a fundamental component of topic selection processes.

Sheryl is also responsible for company engagement in the NICE Medical Technologies Evaluation Programme (MTEP). MTEP considers innovative medical technologies for the development of NICE guidance, and Medtech Innovation Briefings (NICE advice). At October 2018, the outputs include over 68 pieces of NICE guidance and over 156 pieces of NICE advice.

Sheryl joined NICE in 2011 after having previously worked in the NHS.  Sheryl has also worked in the NICE Clinical Guidelines Programme and the NICE Safe Staffing Programme.

Download Presentation